Metformin 500 Mg Oral Tablet, up to 4 tablets a day ( DrugBank: Metformin )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
13	多発性硬化症／視神経脊髄炎	1

13. 多発性硬化症／視神経脊髄炎

---

臨床試験数 : 3,340 /  薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05349474 (ClinicalTrials.gov)	April 26, 2022	21/4/2022	Metformin Treatment in Progressive Multiple Sclerosis	A Double-blind, Placebo Controlled Trial of Metformin Treatment in Progressive Multiple Sclerosis	Secondary Progressive Multiple Sclerosis;Primary Progressive Multiple Sclerosis	Drug: Metformin 500 Mg Oral Tablet, up to 4 tablets a day;Drug: Placebo oral tablet identical to metformin, up to 4 tablets a day	University of California, Los Angeles	NULL	Recruiting	30 Years	65 Years	All	44	Early Phase 1	United States